---
schema_version: "secwatch.filing_event.v1"
accession: "0001829126-24-008141"
form_type: "8-K"
ticker: null
cik: "0000910267"
company_name: "TITAN PHARMACEUTICALS INC"
filed_at: "2024-12-06T23:59:59+00:00"
generated_at: "2026-05-29T06:56:26.597042+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Titan Pharmaceuticals appoints new CEO Chay Weei Jye and changes auditor to Enrome LLP

## Summary
- Appointed Chay Weei Jye as CEO effective Dec 2, 2024; previously CTO of Zchwantech.
- Audit committee selected Enrome LLP as independent auditor for FY 2024, subject to engagement letter.
- Neither company nor anyone on its behalf consulted Enrome on accounting principles or disagreements prior to engagement.
- Mr. Chay, age 52, holds a Bachelor of Computer Science from Universiti Putra Malaysia.
- No family relationships or arrangements with other persons in selection; no reportable events with prior auditor.

## SEC filing metadata
- accession: 0001829126-24-008141
- form_type: 8-K
- cik: 0000910267
- company_name: TITAN PHARMACEUTICALS INC
- filed_at: 2024-12-06T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 4.01, 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/910267/000182912624008141/0001829126-24-008141-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/910267/000182912624008141/titanpharma_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001829126-24-008141
- JSON: https://secwatch.observer/filing/0001829126-24-008141.json
- Plain text: https://secwatch.observer/filing/0001829126-24-008141.txt

## Key facts
- Auditor Changes
  TITAN PHARMACEUTICALS INC engaged Enrome LLP as its auditor.
  - Action: engagement
  - Auditor: Enrome LLP
  source text: The Audit Committee of Titan Pharmaceuticals, Inc. (the "Company") recently completed a selection process to determine the Company's independent registered public accounting firm. As a result of this process, the Audit Committee approved the appointment of Enrome LLP ("Enrome") as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024, subject to satisfactory completion of standard engagement acceptance procedures, and the Company entered into an engagement letter with Enrome on December 3, 2024.
  evidence_url: https://www.sec.gov/Archives/edgar/data/910267/000182912624008141/0001829126-24-008141-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.